Can Nebivolol Reverse Inappropriate Left Ventricular Mass in Hypertensive Patients?

Trial Profile

Can Nebivolol Reverse Inappropriate Left Ventricular Mass in Hypertensive Patients?

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 20 Jun 2014

At a glance

  • Drugs Nebivolol (Primary) ; Metoprolol
  • Indications Hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Mar 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
    • 09 Feb 2013 New source identified and integrated (Mayo Clinic: 11-007035).
    • 29 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top